Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.

Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...

Advertisement Article continues below this ad Yet, this lack of bespoke options is more or less the reality of medicine today. Despite the many biological differences between people of different ...

GlobalData’s Revati Tatake discussed key trends in biopharma which are set to have an impact in 2025 and beyond.

Financial writer discusses Coya Therapeutics, Inc.'s Treg therapies for neurodegenerative diseases like ALS, FTD, and PD.

Advertisement If successful, these trials could revolutionize organ transplantation, helping address the severe shortage of ...

I worked closely with NCI’s Investigational Drug Branch (IDB) from 1990-2016, including as a principal investigator of one of ...

In the last 5 years significant progress has been made in potential dementia treatments, yet many of these treatments come ...

Uganda's highest judicial authority declared on Friday that prosecuting civilians in military courts is unconstitutional, ordering an immediate halt to such trials. The landmark decision benefits ...

Evan Yu, a medical oncologist, treats prostate, bladder, and testicular cancer and is passionate about providing a personalized medical approach to a selection of novel therapies as well as ...

And mercifully, a ball is about to be kicked in anger. Rugby league trials are upon us, with Las Vegas venturers Cronulla, Penrith, Canberra and the Warriors all taking the paddock for the first ...

“Now with the advance in breeding technology we have the possibility to draw from many hundreds of new grape varieties which will allow us to deliver exactly what our customers want, and that’s the ...